Anthim 100 mg/mL
obiltoxaximab · SOLUTION · Elusys Therapeutics, Inc.
No Recall History
Plain English
Anthim is a solution containing obiltoxaximab at 100 mg/mL, taken intravenous. Manufactured by Elusys Therapeutics, Inc..
Key Facts
- Brand Name
- Anthim
- Generic Name
- obiltoxaximab
- NDC Code (Product)
69604-204- Manufacturer
- Elusys Therapeutics, Inc.
- Strength
- 100 mg/mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125509
- Drug Class
- Anthrax Protective Antigen-directed Antibody [EPC]
- Marketing Start
- 03/18/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is Anthim used for?
Anthim contains obiltoxaximab. It is a solution taken intravenous. Consult your doctor for specific uses.
Is Anthim a controlled substance?
Anthim is not classified as a controlled substance by the DEA.
What is the generic name for Anthim?
The generic name for Anthim is obiltoxaximab. There are no other listed brand versions of obiltoxaximab.
What is the NDC code for Anthim 100 mg/mL?
The NDC (National Drug Code) for Anthim 100 mg/mL is 69604-204, listed by Elusys Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)